上海市锦天城律师事务所 关于浙江震元股份有限公司 2025 年第一次临时股东大会的 关于浙江震元股份有限公司 2025 年第一次临时股东大会的 法律意见书 法律意见书 地址：上海市浦东新区银城中路 501 号上海中心大厦 11/12 楼 电话：021-20511000 传真：021-20511999 邮编：200120 上海市锦天城律师事务所 法律意见书 上海市锦天城律师事务所 致：浙江震元股份有限公司 上海市锦天城律师事务所（以下简称"本所"）接受浙江震元股份有限公司 （以下简称"公司"）委托，就公司召开 2025 年第一次临时股东大会（以下简 称"本次股东大会"）的有关事宜，根据《中华人民共和国公司法》（以下简称 《公司法》）、《上市公司股东会规则》等法律、法规、规章和其他规范性文件 以及《浙江震元股份有限公司章程》（以下简称《公司章程》）的有关规定，出 具本法律意见书。 为出具本法律意见书，本所及本所律师依据《律师事务所从事证券法律业务 管理办法》和《律师事务所证券法律业务执业规则（试行）》等规定，严格履行 了法定职责，遵循了勤勉尽责和诚实信用原则，对本次股东大会所涉及的相关事 项进行了必要的核查和验证 ...

Market Overview - The pharmaceutical commercial sector increased by 0.05% on August 20, with Yifeng Pharmacy leading the gains [1] - The Shanghai Composite Index closed at 3766.21, up 1.04%, while the Shenzhen Component Index closed at 11926.74, up 0.89% [1] Stock Performance - Yifeng Pharmacy (603939) closed at 24.27, up 0.87% with a trading volume of 58,700 shares and a turnover of 141 million yuan [1] - Other notable performers include: - Liuyuan Group (603368) at 18.64, up 0.76% [1] - China National Pharmaceutical Group (600511) at 30.01, up 0.60% [1] - Shanghai Pharmaceuticals (601607) at 19.02, up 0.58% [1] - Nanjing Pharmaceutical (600713) at 5.30, up 0.57% [1] Capital Flow - The pharmaceutical commercial sector experienced a net outflow of 377 million yuan from institutional investors, while retail investors saw a net inflow of 367 million yuan [2] - Notable capital flows include: - Yifeng Pharmacy had a net outflow of 9.79 million yuan from institutional investors [3] - Heavy Drug Holdings (000950) saw a net inflow of 7.45 million yuan from institutional investors [3] - Drug Easy Purchase (300937) had a net inflow of 3.82 million yuan from institutional investors [3]

Core Viewpoint - Zhejiang Zhenyuan's stock price has shown a slight increase, indicating positive market sentiment towards the company and its financial health [1] Company Overview - Zhejiang Zhenyuan's latest stock price is 9.40 yuan, up by 0.02 yuan from the previous trading day [1] - The stock reached a high of 9.49 yuan and a low of 9.38 yuan during the trading session, with a total transaction amount of 1.26 billion yuan [1] - The company operates in the pharmaceutical commercial sector, including wholesale and retail, and holds a significant market influence within Zhejiang Province [1] Financial Health - The latest announcement from the company indicates that there are no overdue external guarantees or litigation matters, which reflects a stable financial condition [1] - The net inflow of main funds for Zhejiang Zhenyuan on that day was 742.55 million yuan, with a cumulative net inflow of 109.02 million yuan over the past five trading days [1] - The company's total market capitalization is 31.41 billion yuan, with a circulating market value of 26.50 billion yuan [1]

证券日报网讯8月18日晚间，浙江震元（000705）发布公告称，公司及子公司无逾期对外担保、无涉及 诉讼的对外担保及因担保被判决败诉而应承担损失的情形。 ...

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、担保情况概述 （一）担保基本情况 2025 年 8 月 18 日，浙江震元股份有限公司（以下简称"公司"）与浙江绍兴 瑞丰农村商业银行股份有限公司镜湖支行（以下简称"瑞丰银行镜湖支行"）签 署《最高额保证合同》（合同编号：8911320250012629），为子公司浙江震元生 物科技有限公司（以下简称"震元生物"）2025 年 8 月 18 日至 2026 年 8 月 17 日 期间内，向瑞丰银行镜湖支行取得的人民币 1,000 万元整（壹仟万元整）贷款提 供连带责任保证。 股票代码：000705 股票简称：浙江震元 公告编号：2025-033 浙江震元股份有限公司 关于为子公司震元生物提供担保的进展公告 （二）本次担保事项履行的审议程序 2025 年 4 月 3 日，公司召开第十一届董事会 2025 年第一次临时会议审议通过 《关于为子公司震元生物增加担保额度的议案》，同意公司为震元生物提供信用 担保，12 个月内累计总额不超过人民币 10,000 万元。担保期限自董事会批准同意 日起一年内，担保额度在授权 ...

Group 1 - The total salary of A-share listed company secretaries in 2024 reached 4.086 billion yuan, with an average annual salary of 754,300 yuan [1] - Among the 31 listed pharmaceutical companies, 28 have active secretaries, with the age distribution showing that 57% are between 40-50 years old, 11% are over 50, and 32% are 40 or younger [1] - The educational background of secretaries indicates that 50% hold a bachelor's degree, 46% have a master's degree, and only 4% possess a doctoral degree, with only one secretary having a PhD [1] Group 2 - The average annual salary of secretaries in A-share pharmaceutical companies is 726,500 yuan, with 43% earning below 500,000 yuan, 36% between 500,000-1 million yuan, 18% between 1-2 million yuan, and 3% above 2 million yuan [2] - The top three highest-paid secretaries are from Shanghai Pharmaceuticals, Run Da Medical, and China National Pharmaceutical Group, with salaries of 2.0373 million yuan, 1.6242 million yuan, and 1.2 million yuan respectively [2] - The largest salary decrease was observed for Wang Lei from Renmin Tongtai, with a year-on-year decline of 60.61%, while Zhang Yufeng from Zhejiang Zhenyuan experienced the largest increase at 212.33% [2]

Group 1 - The total salary of A-share listed company secretaries in 2024 reached 4.086 billion yuan, with an average annual salary of 754,300 yuan [1] - Among the 31 listed pharmaceutical companies, 28 have active secretaries, with the age distribution showing that 57% are between 40-50 years old, 11% are over 50, and 32% are 40 or younger [1] - The educational background of secretaries indicates that 50% hold a bachelor's degree, 46% have a master's degree, and only 4% possess a doctoral degree, with only one secretary holding a PhD [1] Group 2 - The average annual salary of secretaries in A-share pharmaceutical companies is 726,500 yuan, with 43% earning below 500,000 yuan, 36% between 500,000-1 million yuan, 18% between 1 million-2 million yuan, and 3% earning over 2 million yuan [2] - The top three highest-paid secretaries are Zhong Tao from Shanghai Pharmaceuticals with 2.0373 million yuan, Zhang Chengxu from Run Da Medical with 1.6242 million yuan, and Luo Lichun from China National Pharmaceutical with 1.2 million yuan [2] - The largest salary decrease was observed for Wang Lei from Renmin Tongtai, with a year-on-year decline of 60.61%, while Zhang Yufeng from Zhejiang Zhenyuan experienced the largest increase at 212.33% [2]

Group 1 - The total salary of A-share listed company secretaries in 2024 reached 4.086 billion yuan, with an average annual salary of 754,300 yuan [1] - Among the 31 listed pharmaceutical companies, 28 have active secretaries, with the age distribution showing that 57% are between 40-50 years old, 11% are over 50, and 32% are 40 or younger [1] - The educational background of secretaries indicates that 50% hold a bachelor's degree, 46% have a master's degree, and only 4% possess a doctoral degree, with only one secretary having a PhD [1] Group 2 - The average annual salary of secretaries in A-share pharmaceutical companies is 726,500 yuan, with 43% earning below 500,000 yuan, 36% between 500,000-1 million yuan, 18% between 1 million-2 million yuan, and 3% earning over 2 million yuan [2] - The top three highest-paid secretaries are Zhong Tao from Shanghai Pharmaceuticals with 2.0373 million yuan, Zhang Chengxu from Run Da Medical with 1.6242 million yuan, and Luo Lichun from China National Pharmaceutical with 1.2 million yuan [2] - The largest salary decrease was observed for Wang Lei from Renmin Tongtai, with a year-on-year decline of 60.61%, while Zhang Yufeng from Zhejiang Zhenyuan experienced the largest increase at 212.33% [2]

关于召开 2025 年第一次临时股东大会通知的更正公告 证券代码：000705 证券简称：浙江震元 公告编号：2025-032 浙江震元股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 浙江震元股份有限公司（简称"公司"）于 2025 年 8 月 5 日在巨 潮资讯网（www.cninfo.com.cn）刊登了《关于召开 2025 年第一次临 时股东大会的通知》（公告编号：2025-031）。经事后核查发现原通 知中部分内容有误，现对相关内容更正。本次更正不涉及原通知的实 质性变更，敬请投资者关注。具体内容如下： 更正前公告内容： 附件 1： 参加网络投票的具体操作流程 三、 通过深交所互联网投票系统投票的程序 易所投资者网络服务身份认证业务指引（2016 年修订）》的规定办理 身份认证，取得"深交所数字证书"或"深交所投资者服务密码"。 具 体 的 身 份 认 证 流 程 可 登 录 互 联 网 投 票 系 统 http://wltp.cninfo.com.cn 规则指引栏目查阅。 http://wltp.cninfo.com.cn 在规定时间内 ...

浙江震元股份有限公司 证券代码：000705 证券简称：浙江震元 公告编号：2025-032 浙江震元股份有限公司（简称"公司"）于 2025 年 8 月 5 日在巨 潮资讯网（www.cninfo.com.cn）刊登了《关于召开 2025 年第一次临 时股东大会的通知》（公告编号：2025-031）。经事后核查发现原通 知中部分内容有误，现对相关内容更正。本次更正不涉及原通知的实 质性变更，敬请投资者关注。具体内容如下： 关于召开 2025 年第一次临时股东大会通知的更正公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 1.互联网投票系统开始投票的时间为 2024 年 12 月 4 日 9：15－15： 00。 2.股东通过互联网投票系统进行网络投票，需按照《深圳证券交 易所投资者网络服务身份认证业务指引（2016 年修订）》的规定办理 身份认证，取得"深交所数字证书"或"深交所投资者服务密码"。 具 体 的 身 份 认 证 流 程 可 登 录 互 联 网 投 票 系 统 http://wltp.cninfo.com.cn 规则指引栏目查阅。 3.股东根 ...